ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients with CKD from CSA-AKI and MAKE
Jack Sun
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 20 of 283 Results
A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People with ALS
Namita Goyal
- OPEN TO ACCRUAL
An Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Bassam Yaghmour
- SUSPENDED
A Long-term Follow-up Study of Sotatercept for PAH Treatment
Bassam Yaghmour
- SUSPENDED
JanusRectalCancerTrial: PhII TripletVSDoublet ChemoClinicalComplete Response Pa w/LocallyAdvRectalCa
Jason Zell
- OPEN TO ACCRUAL
A Phase 1 Study of CD19-targeted NEX-T CAR T Cells in Participants with RMS or PMS
Michael Sy
- OPEN TO ACCRUAL
A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimer
Priyanka Iyer
- OPEN TO ACCRUAL
Evaluate Safety of a Single Intravitreal Injection of RTx-015 in Patients with Retinitis Pigmentosa
Baruch Kuppermann
- OPEN TO ACCRUAL
Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females with Obstetric Injury (Dign
Joseph Carmichael
- OPEN TO ACCRUAL
Impact of Intraoperative ICG on Functional Outc in RARP
David Lee
- OPEN TO ACCRUAL
SAFETY STUDY OF AAV2-GDNF IN MSA
Nicolas Phielipp
- OPEN TO ACCRUAL
CABA-201 for Generalized Myasthenia Gravis
Ali Habib
- OPEN TO ACCRUAL
Evaluate the Safety & Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy
Tahseen Mozaffar
- OPEN TO ACCRUAL
Study to Evaluate the Safety and Efficacy of Light Dose (Fluence) in Subjects with Port Wine Stain
Kristen Kelly
- OPEN TO ACCRUAL
Comparison of potassium binders in the ER
Wei Ling Lau
- OPEN TO ACCRUAL
Dietary Sodium Intake and Blood pressure in Living Kidney Donors (SPLID Trial)
Ekamol Tantisattamo
- OPEN TO ACCRUAL
PhIII Random Placebo-controlled Multicenter Study AZD2936 in Comb w/Chemo Adj Tx Biliary Tract Ca
Farshid Dayyani
- OPEN TO ACCRUAL
Investigate the efficacy and safety of anifrolumab in adults with chronic and/or subacute cutaneous
Michelle Min
- OPEN TO ACCRUAL
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
Sanjay Kedhar
- OPEN TO ACCRUAL
RandPhIIStIberdomideMaintaenanceThepFollowIdecabtageneVicleucelCARTMultipleMyeloma
Lisa Xingguang Lee
- OPEN TO ACCRUAL